New drug hope for rare bone cancer patients

Patients with a rare bone cancer of the skull and spine — chordoma — could be helped by existing drugs, suggest scientists. In the largest genomics study of chordoma to date, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply